MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • Patient Community Day at MSToronto2026
  • The ECTRIMS Podcast at MSToronto2026
  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Panellists at Patient Community Day 2026, held at the conclusion of MSToronto2026, are shown in discussion on stage.

Patient Community Day at MSToronto2026

MStranslate
November 6, 2026
Community, ECTRIMS, Events, Research
The word Toronto is shown displayed in large lettering on the edge of what could be a town square in downtown Toronto.

The ECTRIMS Podcast at MSToronto2026

MStranslate
November 5, 2026
Conferences, ECTRIMS, Research
1 Comment
3D medical illustration of HIV virus cells.

Antiviral Reverses Disability in Mouse Model of MS

MStranslate
September 28, 2026
Research, Treatments
cognition

Assessing & Monitoring Cognition in MS

MStranslate
August 11, 2026
Cognition, Research
News

Potential Changes to MS Treatment Access in Australia

MStranslate
July 2, 2026
Treatments

A New Marker to Predict MS Progression

MStranslate
May 27, 2014
Basic Sciences
When people are diagnosed with MS, it is very difficult to predict how their condition will progress as each individual will often have different outcomes. This leads to a large level of uncertainty for the...

The PET/CT Scanner & Its Uses for Multiple Sclerosis

MStranslate
May 2, 2014
Neuroimaging
Professor Roger Ordidge, Chair of Imaging Science at the University of Melbourne, provides an insight into the new PET/CT scanner located at the Melbourne Brain Centre and explains how it might help people...

An Explanation of Magnetic Resonance Imaging (MRI)

MStranslate
May 1, 2014
Neuroimaging
As magnetic resonance imaging (MRI) plays a key role in the diagnosis of multiple sclerosis, we took the opportunity to ask Professor Roger Ordidge, Chair of Imaging Science at The University of Melbourne,...

A New Technique to Assess Outcomes of Optic Neuritis

MStranslate
April 30, 2014
Neuroimaging
Optic neuritis (inflammation of the optic nerve, (ON)) causes visual loss and is a common early symptom of multiple sclerosis (MS). Patients with ON present to hospital early and identifying measurements of...

Understanding the Different Outcomes of Optic Neuritis

MStranslate
April 29, 2014
Neuroimaging, Research
Optic neuritis (inflammation of the optic nerve) is a common side-effect of multiple sclerosis (MS) and leads to many sight-related difficulties, including blurriness, impaired colour recognition and problems...

An Introduction to the PrevANZ Trial

MStranslate
March 28, 2014
Lifestyle, Research, Vitamin D
Filmed during our MSBase Feature Week, this short video with Associate Professor Helmut Butzkueven introduces PrevANZ, a Multiple Sclerosis Research Australia led study investigating the role Vitamin D...

Fingolimod After Natalizumab & Short-term Relapse Risk

MStranslate
March 27, 2014
Fingolimod, Natalizumab, Research, Treatments
Dr Vilija Jokubaitis et al Natalizumab (Tysabri) is an antibody used for the treatment of multiple sclerosis (MS). It is currently the strongest drug available for the treatment of MS, however, it has also...

An Introduction to MSBase by A/Prof Helmut Butzkueven

MStranslate
March 25, 2014
Research
MSBase is an international multiple sclerosis (MS) registry that is helping answer many questions about MS. In this short video, Associate Professor Helmut Butzkueven (neurologist, MS researcher) explains...

Sex as a Determinant of Relapse Incidence & MS Progression

MStranslate
March 20, 2014
Research
Dr Tomas Kalincik et al Relapses of MS activity present with worsening of neurological symptoms and are usually followed by periods of stability. These are a defining feature of relapsing-remitting MS, the...
collaboration

MStranslate and Melbourne Brain Centre Announce Collaboration

MStranslate
February 20, 2014
Collaboration
MStranslate is excited to announce a new collaboration with the Melbourne Brain Centre at Royal Melbourne Hospital (MBC@RMH).  This opportunity follows MStranslate's presentation to the Melbourne Brain...
  1. 27
  2. 28
  3. 29
  4. 30
  5. 31
  6. 32
  7. 33

Recent Posts

  • Patient Community Day at MSToronto2026
  • The ECTRIMS Podcast at MSToronto2026
  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia

Recent Comments

  • Patient Community Day at MSToronto2026 on The ECTRIMS Podcast at MSToronto2026
  • MStranslate on Multiple Sclerosis Research In 2026
  • MStranslate on Multiple Sclerosis Research In 2026
  • K on Multiple Sclerosis Research In 2026
  • Mohammad on Multiple Sclerosis Research In 2026

Calendar

November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Sep    

Archives

Categories

Posts

  • Patient Community Day at MSToronto2026
  • The ECTRIMS Podcast at MSToronto2026
  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.